Who are the key players in North America Next-Generation Sequencing Market industry?

The top 5 players are Illumina, Thermo Fisher Scientific, Pacific Biosciences, Agilent Technologies, and Qiagen. These companies dominate the market with advanced platforms, comprehensive genomic solutions, and strong R&D investments, enabling adoption across clinical research, diagnostics, and pharmaceutical sectors in North America.

Which segment accounted for the largest North America Next-Generation Sequencing Market share?

The oncology application segment accounted for the largest market share, driven by rising cancer prevalence and the demand for precision medicine. NGS enables comprehensive genomic profiling in cancer research, aiding in targeted therapies and clinical decision-making, as widely adopted by hospitals and research institutes.

What are the factors driving the North America Next-Generation Sequencing Market?

Key drivers include advancements in sequencing technologies, decreasing costs, and expanding applications in clinical diagnostics. For example, Thermo Fisher Scientific's launch of cost-effective high-throughput sequencers has enabled broader access for genomic analysis in healthcare, accelerating the market’s adoption and growth.

Which type accounted for the largest North America Next-Generation Sequencing Market share?

The sequencing by synthesis (SBS) technology, mainly popularized by Illumina, holds the largest market share due to its high accuracy, throughput, and scalability. Its robust performance and wide compatibility with various genomic applications make SBS the preferred choice among research institutions and clinical laboratories.

Home Healthcare

North America Next-Generation Sequencing Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

Name: North America Next-Generation Sequencing Market
Brand: Bussiness Insights

North America Next-Generation Sequencing Market: by Type (Whole Genome Sequencing, Whole Exome Sequencing, Targeted Sequencing, RNA Sequencing, Methylation Sequencing, Other Types), Application (Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agricultural & Animal Research, Others), Distribution Channels (Direct Sales, Distributors, Online Sales, Retail Stores, Others), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Single Molecule Real Time Sequencing, Nanopore Sequencing, Pyrosequencing, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025

Last Updated: 31-07-2025 | Format: PDF | Report ID:20420

North America Next-Generation Sequencing Market (2025-2035)

The North America Next-Generation Sequencing (NGS) market is experiencing rapid advancement driven by technological innovations and expanding applications across healthcare and life sciences. This market encompasses a range of sequencing technologies, including whole genome, whole exome, targeted sequencing, and more, accessible via diverse channels. The sector is witnessing increased adoption for personalized medicine, clinical diagnostics, and research, making it crucial in modern healthcare infrastructure.

Latest Market Dynamics

Key Drivers

Rising demand for personalized medicine: Precision healthcare initiatives are propelling NGS utilization as clinicians rely on comprehensive genomic data for informed treatment. In 2024, Illumina launched new clinical solutions making NGS more accessible for oncology and rare disease diagnostics.

Declining sequencing costs and faster turnaround times: Technological breakthroughs have reduced sequencing costs substantially while improving data accuracy. Pacific Biosciences' recent partnerships with academic centers have enabled larger population sequencing projects at lower costs.

Integration of AI and bioinformatics: Advanced analytics and AI are increasingly merged with NGS platforms to accelerate data interpretation. Thermo Fisher Scientific’s Ion Torrent platform now offers integrated analytics powered by machine learning.
Expansion of liquid biopsy applications: NGS is being adopted for noninvasive cancer diagnostics through liquid biopsies. Guardant Health's North American launch of expanded liquid biopsy panels in 2024 demonstrates this trend.

Key Opportunities

Growing clinical adoption in oncology: Increased clinical evidence supports NGS-guided cancer therapy selection. Roche’s recent partnership with US healthcare networks to provide comprehensive genomic profiling panels exemplifies this opportunity.
Agricultural genomics: NGS is being leveraged to enhance crop and livestock traits. In 2024, Agilent Technologies collaborated with agrigenomics firms to develop and validate high-throughput sequencing assays for North American agriculture.

Data management, storage, and analysis: The massive data output from NGS requires robust, scalable, and interoperable data infrastructure. QIAGEN faces ongoing challenges in streamlining end-to-end genomic data workflows for clients.
Regulatory and reimbursement complexities: Changing regulatory landscapes and slow reimbursement pathways impede the integration of NGS into clinical care. Oxford Nanopore continues to navigate these hurdles as it expands clinical diagnostics offerings in North America.

High initial investment and operational costs: While costs per genome have fallen, total outlay for NGS infrastructure remains significant. Genapsys has delayed potential market expansion due to capital constraints.
Limited skilled workforce: Demand for bioinformatics professionals outpaces supply, slowing the adoption rate. Bio-Rad Laboratories has invested in workforce development initiatives, but talent shortage persists.

North America NGS Market Share by Type, 2025

By type, Whole Genome Sequencing dominates the North America NGS market, driven by widespread research and precision medicine needs. Whole Exome and Targeted Sequencing segments follow, serving applications in diagnostics and specific gene panels. Technological innovations continue to broaden the accessibility and utility of RNA and Methylation sequencing.

North America NGS Market Share by Application, 2025

Diagnostics take the leading share of the NGS application market in North America, underscoring the transition of sequencing technologies from research to clinical environments. Drug discovery and biomarker discovery remain substantial, followed by mounting implementation in personalized medicine. Agricultural and animal research, while smaller, is growing as adoption broadens.

North America NGS Market Revenue (USD Million), 2020-2035

From 2020 to 2035, the North America NGS market is projected to rise significantly. Revenue is anticipated to grow from 3,300 million USD in 2020 to 11,900 million USD by 2035, reflecting rapid adoption in clinical diagnostics, expanding applications, and supportive regulatory environments. This growth is seen across all major segments, with particularly robust increases in clinical and biopharma sectors.

North America NGS Market YOY Growth (%), 2020-2035

Year-over-year growth in the North America NGS market is expected to peak during 2025–2030, averaging 10.5% annually. As the market matures and broadens its base in diagnostics and research, growth rates will gradually normalize post-2030 to an estimated 7% by 2035, maintaining the region's global leadership in sequencing technologies.

North America NGS Market Share by Country/Region, 2025

The United States accounts for the dominant share of the North America NGS market in 2025, propelled by early technology adoption, strong R&D infrastructure, and leadership in precision medicine. Canada and Mexico collectively represent a growing portion, benefiting from expanding healthcare access and investment.

North America NGS Market Share by Company, 2025

Illumina commands the largest share of the North American NGS market in 2025, leveraging its broad NGS platform offerings and strategic partnerships. Thermo Fisher Scientific and Pacific Biosciences are next, each contributing through technological innovation and market expansion, alongside a competitive field of emerging companies.

North America NGS Market Share by Buyer, 2025

Academic and research institutions remain the largest buyers of NGS solutions in North America, leveraging funding for population-scale studies and clinical research. Clinical laboratories and hospitals are fast-growing buyers as diagnostics become more mainstream, with pharmaceutical and biotech companies maintaining steady demand for drug discovery.

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	5450
Regions	United States, Canada, Mexico
Segments	Whole Genome Sequencing, Whole Exome Sequencing, Targeted Sequencing, RNA Sequencing, Methylation Sequencing, Other Types; Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agricultural & Animal Research, Others; Distribution Channels; Technology; Organization Size
Players	Illumina, Thermo Fisher Scientific, Pacific Biosciences, Oxford Nanopore Technologies, BGI Genomics, Agilent Technologies, QIAGEN, F. Hoffmann-La Roche, PerkinElmer, Eurofins Scientific, Macrogen, Genomatix, Genapsys, GENEWIZ, Bio-Rad Laboratories

Key Recent Developments

June 2024: Illumina launches its latest NovaSeq X Plus system, doubling data output and reducing whole genome sequencing cost per sample.
July 2024: Thermo Fisher Scientific partners with major North American cancer centers to deploy advanced Ion Torrent Genexus platforms for clinical oncology.
August 2024: Roche collaborates with multiple US-based personalized medicine labs to expand comprehensive cancer genomic profiling services.
September 2024: Agilent Technologies introduces new SureSelect NGS panels tailored for rapid agricultural genomics deployments.
October 2024: QIAGEN unveils QIAseq Multimodal Panels, streamlining biomarker discovery for clinical and research clients in North America.

Frequently asked questions

Key Questions Answered

»What is the market size and growth rate of the global and regional market by various segments?
»What is the market size and growth rate of the market for selective countries?
»Which region or sub-segment is expected to drive the market in the forecast period?
»What factors are estimated to drive and restrain the market growth?
»What are the key technological and market trends shaping the market?
»What are the key opportunities in the market?
»What are the key companies operating in the market?
»Which company accounted for the highest market share?

Why Choose Bussiness Insights?

»Strong Industry Focus
»Extensive Product Offerings
»Customer Research Services
»Robust Research Methodology
»Comprehensive Reports
»Latest Technological Developments
»Value Chain Analysis
»Potential Market Opportunities
»Growth Dynamics
»Quality Assurance
»Post-sales Support
»Regular Report Updates